Springer Nature
Browse
40425_2019_545_MOESM2_ESM.docx (662.86 kB)

Additional file 2: of Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

Download (662.86 kB)
journal contribution
posted on 2019-03-12, 05:00 authored by Abhishek Kashyap, Tamara Thelemann, Richard Klar, Sandra Kallert, Julia Festag, Melanie Buchi, Lisa Hinterwimmer, Monika Schell, Sven Michel, Frank Jaschinski, Alfred Zippelius
Figure S1. hCD39-specific ASO inhibit degradation of extracellular ATP in a human Burkitt’s lymphoma cell line. (DOCX 662 kb)

Funding

Bundesministerium fĂźr Bildung und Forschung

History

Usage metrics

    Springer Nature

    Categories

    Keywords

    CD39CD73EctonucleotidaseAntisense oligonucleotide (ASO)ImmunotherapyATPAdenosine

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC